Sedative but not anxiolytic properties of benzodiazepines ave mediated by the GABAA receptor α1 subtype

被引：768

作者：

McKernan, RM ^{[1
]}

Rosahl, TW ^{[1
]}

Reynolds, DS ^{[1
]}

Sur, C ^{[1
]}

Wafford, KA ^{[1
]}

Atack, JR ^{[1
]}

Farrar, S ^{[1
]}

Myers, J ^{[1
]}

Cook, G ^{[1
]}

Ferris, P ^{[1
]}

Garrett, L ^{[1
]}

Bristow, L ^{[1
]}

Marshall, G ^{[1
]}

Macaulay, A ^{[1
]}

Brown, N ^{[1
]}

Howell, O ^{[1
]}

Moore, KW ^{[1
]}

Carling, RW ^{[1
]}

Street, LJ ^{[1
]}

Castro, JL ^{[1
]}

Ragan, CI ^{[1
]}

Dawson, GR ^{[1
]}

Whiting, PJ ^{[1
]}

机构：

[1] Merck Sharp & Dohme Ltd, Res Labs, Neurosci Res Ctr, Harlow CM20 2QR, Essex, England

来源：

NATURE NEUROSCIENCE | 2000年 / 3卷 / 06期

关键词：

D O I：

10.1038/75761

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

GInhibitory neurotransmission in the brain is largely mediated by GABA(A) receptors. Potentiation of GABA receptor activation through an allosteric benzodiazepine (BZ) site produces the sedative, anxiolytic, muscle relaxant, anticonvulsant and cognition-impairing effects of clinically used BZs such as diazepam. We created genetically modified mice (alpha(1) H101R) with a diazepam-insensitive alpha(1) subtype and a selective BZ site ligand, L-838,417, to explore GABA(A) receptor subtypes mediating specific physiological effects. These two complimentary approaches revealed that the alpha(1) subtype mediated the sedative, but not the anxiolytic effects of benzodiazepines. This finding suggests ways to improve anxiolytics and to develop drugs for other neurological disorders based on their specificity for GABA(A) receptor subtypes in distinct neuronal circuits.

引用

页码：587 / 592

页数：6

共 34 条

[1] Regional differences in the inhibition of mouse in vivo [3H]Ro 15-1788 binding reflect selectivity for α1 versus α2 and α3 subunit-containing GABAA receptors
Atack, JR
Smith, AJ
Emms, F
McKernan, RM
[J]. NEUROPSYCHOPHARMACOLOGY, 1999, 20 (03) : 255 - 262
[2] Barnard EA, 1998, PHARMACOL REV, V50, P291
[3] Comparison of benzodiazepine (BZ) receptor agonists in two rodent activity tests
Bayley, PJ
Bentley, GD
Jackson, A
Williamson, D
Dawson, GR
[J]. JOURNAL OF PSYCHOPHARMACOLOGY, 1996, 10 (03) : 206 - 213
[4] On the elevated plus maze the anxiolytic like effects of the 5-HT1A agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT1A partial agonist, buspirone, are blocked by the 5-HT1A antagonist, WAY 100635
Collinson, N
Dawson, GR
[J]. PSYCHOPHARMACOLOGY, 1997, 132 (01) : 35 - 43
[5] USE OF THE ELEVATED PLUS-MAZE IN THE SEARCH FOR NOVEL ANXIOLYTIC AGENTS
DAWSON, GR
TRICKLEBANK, MD
[J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (02) : 33 - 36
[6] DUGGAN MJ, 1990, J BIOL CHEM, V265, P3831
[7] GABA(A)-RECEPTOR HETEROGENEITY IN THE ADULT-RAT BRAIN - DIFFERENTIAL REGIONAL AND CELLULAR-DISTRIBUTION OF 7 MAJOR SUBUNITS
FRITSCHY, JM
MOHLER, H
[J]. JOURNAL OF COMPARATIVE NEUROLOGY, 1995, 359 (01) : 154 - 194
[8] 5 SUBTYPES OF TYPE-A GAMMA-AMINOBUTYRIC-ACID RECEPTORS IDENTIFIED IN NEURONS BY DOUBLE AND TRIPLE IMMUNOFLUORESCENCE STAINING WITH SUBUNIT-SPECIFIC ANTIBODIES
FRITSCHY, JM
BENKE, D
MERTENS, S
OERTEL, WH
BACHI, T
MOHLER, H
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (15) : 6726 - 6730
[9] NEURON-SPECIFIC EXPRESSION OF GABA(A)-RECEPTOR SUBTYPES - DIFFERENTIAL ASSOCIATION OF THE ALPHA(1)-SUBUNIT AND ALPHA(3)-SUBUNIT WITH SEROTONERGIC AND GABAERGIC NEURONS
GAO, B
FRITSCHY, JM
BENKE, D
MOHLER, H
[J]. NEUROSCIENCE, 1993, 54 (04) : 881 - 892
[10] STABLE EXPRESSION OF MAMMALIAN TYPE-A GAMMA-AMINOBUTYRIC-ACID RECEPTORS IN MOUSE CELLS - DEMONSTRATION OF FUNCTIONAL ASSEMBLY OF BENZODIAZEPINE-RESPONSIVE SITES
HADINGHAM, KL
HARKNESS, PC
MCKERNAN, RM
QUIRK, K
LEBOURDELLES, B
HORNE, AL
KEMP, JA
BARNARD, EA
RAGAN, CI
WHITING, PJ
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (14) : 6378 - 6382

← 1 2 3 4 →